BCL2 and myocardial infarction: The present research demonstrated that QRHX dose-dependently decreased the myocardial infarct size; improved cardiac function; decreased the levels of myocardial enzymes, oxidative stress and apoptosis; and blocked the activity of caspase-3 and Bax/Bcl-2.